NEW YORK (GenomeWeb) – WaferGen Biosystems reported after the close of the market Thursday that its first quarter revenues jumped nearly 700 percent year over year, and the firm cut its loss sharply.

The Fremont, Calif.-based genetic analysis products firm, reported total revenues of $1.4 million for the three months ended March 31, up from $178,487 in revenues for the first quarter of 2013. Its product revenue was $1.3 million versus $95,154 year over year, while license and royalty revenue increased to $125,000 from $83,333.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.